Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes. (Q53752632)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Josep-Maria Ribera

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Guillermo F Sanz

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

19

object named as

David C Linch

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Anthony H. Goldstone

17

object named as

Anthony H Goldstone

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1

object named as

Karl S Peggs

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Premini Mahendra

11

object named as

Premini Mahendra

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Stephen Mackinnon

21

object named as

Stephen Mackinnon

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

15

object named as

Kirsty Thomson

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Álvaro Urbano-Ispizua

6

object named as

Alvaro Urbano-Ispizua

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2

object named as

Anna Sureda

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

3

object named as

Wendi Qian

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Dolores Caballero

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Ann Hunter

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

James Cavet

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Miguel Canales

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Javier Garcia-Conde

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Donald Milligan

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Reyes Arranz

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Ivan Alvarez

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jorge Sierra

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

UK and Spanish Collaborative Groups

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

0 references

publication date

1 October 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

British Journal of Haematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

139

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

70-80

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17854309%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06759.X

21 January 2018

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06759.X

21 January 2018

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06759.X

21 January 2018

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06759.X

21 January 2018

Applying Cox regression to competing risks.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06759.X

21 January 2018

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06759.X

21 January 2018

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06759.X

21 January 2018

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06759.X

21 January 2018

Role of allogeneic stem cell transplantation in relapsed or refractory Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06759.X

21 January 2018

High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in pat

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06759.X

21 January 2018

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06759.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53752632&oldid=1744096529"